Status:
COMPLETED
The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome
Lead Sponsor:
Hangzhou Agile Groups Network Technology Co., Ltd.
Conditions:
Anemia
Skin Condition
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi...
Eligibility Criteria
Inclusion
- Female, aged 18 to 35;
- Hemoglobin concentration level below 110g/L based on WHO diagnostic criteria for anemia;
- Agree not to take any drugs, supplements, or other dairy products during the trial;
- Agree not to take any other medications or supplements containing iron during the trial;
- Willing to refrain from participating in other interventional clinical studies during the trial period;
- Be able to fully understand the purpose, benefits and potential risks including side effects of the research;
- Willing to obey all test requirements and procedures;
- Informed consent signed.
Exclusion
- Anemia caused by organic diseases;
- Subject who is in the treatment of gastrointestinal symptoms;
- Lactose intolerance;
- Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
- Controlling diet, exercising, or taking medications to control weight or affect appetite in the last 3 months;
- Subject who has any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
- Abuse alcohol or other drugs, supplement or OTC drugs currently or n the past may cause bowel dysfunction or can affect test result evaluation;
- Frequently use of medications that may affect gastrointestinal function or the immune system according to investigator's judgment;
- Take laxatives or other substances that promote digestion 2 weeks before the trail start;
- Subject who used drugs or supplements of iron agent 10 days before the beginning of the trial;
- Pregnant or lactating women or those planning to become pregnant during the trial;
- PI deems that subjects could not fully cooperate with trial arrangements.
Key Trial Info
Start Date :
September 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06066151
Start Date
September 10 2023
End Date
December 15 2023
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Raison CMA Lab
Shanghai, Shanghai Municipality, China